| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5656477 | HPB | 2017 | 7 Pages |
Abstract
FRS is robust and able to stratify the risk of developing CR-POPF following PD in diverse North American academic and non-academic institutions. The FRS should be used in research and to guide clinical management of patients post PD in these institutions.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Jan Grendar, Zeljka Jutric, Julie N. Leal, Chad G. Ball, Kimberly Bertens, Elijah Dixon, Chet W. Hammill, Zachary Kastenberg, Pippa H. Newell, Flavio Rocha, Brendan Visser, Ronald F. Wolf, Paul D. Hansen,